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Dundergoing surgery and added the ECMO event rate; we
were unable to capture neurologic events that would be an
important component of assessing morbidity. Our data set
did not allow for examination of unplanned reintervention
rates. Future studies, such as those using the linked Society
of Thoracic Surgeons-PHIS database, that provide insight
on these variables can further help with prioritization
schemes. Finally, our data do not explain the reason for
the significant variation in care for the various procedures.
Perhaps center- or institution-specific features have some
impact in this regard. These could be the subject of future
investigations.
Our results have the following implications for QI efforts
in pediatric cardiac surgery. First, the data might be used as
a guide to prioritize local QI efforts at individual institutions
based on their case mix.23 We have provided a number of
‘‘priority lists’’ based on various ranking algorithms; these
can be modified as desired and provide a concept of which
areas to focus on to implementQImeasures. For professional
organizations, our findingsmight be useful in targeting large-
scale QI efforts beyond subjective, consensus opinion; other
data sets can be used for validation of such schemes or to de-
velop more robust prioritization schemes in an objective
manner. Finally, our findings are relevant to current policy
discussions regarding healthcare reform and associated costs
as one may use similar approaches to identify high-leverage
procedures, in terms of their potential for not only improving
patient outcomes but also reducing excess cost.
Our study does not assess the extent to which QI could
reduce any parameter for each procedure. Therefore, indi-
vidual organizations and improvement teams would likely
want to consider other factors in setting their QI priorities.
In particular, it would be important to weight the potential
of each procedure for a QI initiative, even though we tried
to focus on the higher-volume procedures.CONCLUSIONS
Future work should aim to improve our current under-
standing of processes of care associated with observed out-
comes and objectively lead to QI initiatives that improve
care across many institutions that currently care for children
with congenital heart disease.References
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Dr James Jaggers (Aurora, Colo). As you describe, measure-
ment of quality and performance in the management of our pa-
tients with congenital heart disease is challenging because of the
vast variety of congenital defects, the variability of presentation,
and the severity of illness. It makes it difficult for even complex
analyses like this one to capture that. I do like your idea of a prior-
itization system, something that takes into account not only the
mortality figures but also those areas that we know are problems
(eg, reintervention, readmission). You use the PHIS database,rdiovascular Surgery c Volume 145, Number 3 639
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Dwhich is a powerful tool and is becoming increasingly used in our
field. But it has important limitations as you described. It is retro-
spective and observational. It is fraught with coding errors, and it
captures charges but not cost. It does have a lot of power advan-
tages, so eventually efforts like this to improve our quality are go-
ing to take a combination of different databases, such as registries
and the administrative databases. With that comment aside, I have
a couple questions for you.
Why did you use the RACHS system in your prioritization
rather than the more newly combined stratification system, the Eu-
ropean Association for Cardio-Thoracic Surgery (EACTS)/Soci-
ety of Thoracic Surgeons (STS)? One of the reasons you did this
study seems to be because you did not like the consensus-based
classification. Why not use a data-derived classification system
like the EACTS-STS system?
Dr Eghtesady. Simplistically, because the RACHS is an easy al-
gorithm that allows pulling procedures out of administrative data-
bases based on International Classification of Diseases 9th Revision
codes. You basically have to access the STS/EACTS database. There
is no algorithm that you can apply to the administrative database to be
able to pull that data, but I think one could do exactly the same thing
with the STS database, which is ease of access to the PHIS database
and being able to pull the data using the RACHS algorithm.
Dr Jaggers. Just by way of clarification, when you talk about
LOS in your study, does that include the preoperative LOS or is
this strictly postoperative LOS?
Dr Eghtesady. No, it is from admission to discharge, so there
could be a period of preoperative stay included in that.
Dr Jaggers.That is an important distinction whenwe start com-
paring different databases and outcomes that are related to LOS. I
am always a little skeptical about complication rates in the PHIS
database. As you know, hospitals get reimbursed according to
these diagnosis-related groups and the rates of complications. Is
there any way within your study that you can reassure us that
the complication rates are not significantly different between insti-
tutions and different payors?
Dr Eghtesady. Yes and no. You are absolutely right, and I am
skeptical of them to some extent. With that said, just looking at640 The Journal of Thoracic and Cardiovascular SurgICU LOS, which others have shown to be a surrogate marker of
complications, the data (ie, the prioritization and all that) still
hold and correlated with the events rate that we saw, so even
though we may be undercapturing the events and this is a deriva-
tion of a derivation, there is a lot of reach there if you will. I
think the data you see are not necessarily inaccurate. I think
the data are underrepresenting; we are not seeing all the compli-
cations that should be there. Additional effort needs to go into
providing definitions. For example, neurologic events is missing,
and specifically the reason is until 2010 the database, PHIS data-
base, did not have a category to identify whether the child pre-
senting at admission had a neurologic problem at baseline or
not, so using the definitions that have been used in the past would
have given us an unmeaningful response. The database includes
select events and is not completely accurate, but my confidence
lies in the fact that it correlates nicely with ICU LOS,
which is a reasonable assumption to say it is a surrogate for
complications.
Dr Jaggers. As you have described, the PHIS database’s
advantage is that it contains more than 5 million inpatient en-
counters and with that comes charge data for which cost data
can be derived. We are going to be judged on value essentially
and quality and cost. What is your opinion as you look for-
ward? Do you think it is time for us to start including cost
within these prioritization screens? What do you think about
that?
Dr Eghtesady. Great question, and the short answer is yes. I
talked about it with Matt Hall, but the reality was for us to be
able to pull that off was going to be challenging because it
seemed like we had so much in there. You and Ross Ungerleider
were kind enough to provide reference to me, an article that you
guys had published a long time ago where you looked at costs at
Duke with 140 procedures and looked at variation and how
ASD repair was a reliable cost versus VSD, which was more
variable. That is an important thing to look at, and in the future
that would be one of the things that would definitely be worth
looking at.
Dr Jaggers. Thank you.ery c March 2013
